-
marketed under the
brands CellCept (mycophenolate
mofetil by Roche) and
Myfortic (mycophenolate
sodium by Novartis).
Cellcept was
developed by a South...
-
derivative which was
eventually approved as an
immunosuppressive drug
called CellCept. He
contributed more than 400
technical papers and
edited 12 books. Allison...
-
response measured in
magnetoencephalography Mycophenolate mofetil (tradename
CellCept), an
immunosuppressant drug used to
prevent rejection in
organ transplantation...
-
facility to
Lonza and
acquired an
exclusive right to
purchase Lonza's
mammalian cell culture manufacturing facility under construction in Singapore. In June 2007...
- by
autoantibodies targeting aquaporin 4 (AQP4), a
channel protein in the
cell membrane that
allows water to p****
through the membrane. AQP4
monomers form...
-
injection of steroids, such as
dexamethasone Immunosuppressant drugs, such as
CellCept (mycophenolic acid): In
recent years,
adjuvant drugs,
especially biologics...
- 191187. PMID 32611669. "FDA Alert:
Mycophenolate Mofetil (marketed as
CellCept) and
Mycophenolic Acid (marketed as Myfortic)". U.S. Food and Drug Administration...
- Rosenthal, Don; Dutz, Jan; Ho,
Vincent (July 1, 2003). "Mycophenolate
Mofetil (
CellCept) for Psoriasis: A Two-Center, Prospective, Open-Label
Clinical Trial"....
-
started at the
CEPT Working Group GSM (Group
Special Mobile) in 1982
under the
umbrella of
CEPT. In 1988, ETSI was established, and all
CEPT standardization...
- HIV
protease inhibitor Invirase 1999 –
Released immunosuppressive agent Cellcept 2000 –
Released antiemetic drug Kytril,
developed to
combat the side effects...
